Brief: Aarti Drugs Gets EIR From US FDA Concluding Inspection As Closed
29/07/2024 15:24
July 29 (Reuters) - Aarti Drugs Ltd ADRG.NS :
* US FDA EIR AT MANUFACTURING FACILITY OF UNIT AT BADDI,
HIMACHAL
PRADESH
* GETS EIR FROM USFDA CONCLUDING INSPECTION AS CLOSED
Source text for Eikon: ID:nNSE4XTgJD
Further company coverage: ADRG.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aarti Drugs
See all newsBrief: Aarti Drugs Says Adhish P. Patil Appointed MD For 5 Years From Oct 1
Brief: Aarti Drugs Posts June-Qtr Consol Net Profit 501.7 Million Rupees
Brief: Aarti Drugs March-Quarter Consol Profit 552.6 Million Rupees
Brief: Aarti Drugs Dividend 2 Rupees Per Share
Brief: Aarti Drugs Dec-Quarter Consol Net Profit 405.4 Million Rupees